Skip to main content
Watch Insiders
PCSA filings

Corporate insider profile

David Young Filing Activity

Latest reported as Pres. Research & Development of Processa Pharmaceuticals, Inc. (PCSA).

Purchase filings
5
Reported companies
1
Net open-market value
$22,945
Latest transaction
Jun 15, 2026

Affiliated corporations

Reported company relationships

PCSALatest reported

Processa Pharmaceuticals, Inc.

Pres. Research & Development

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 15, 2026Processa Pharmaceuticals, Inc. (PCSA)Pres. Research & DevelopmentOpen Market Purchase2,067$2.22$4,589
May 29, 2026Processa Pharmaceuticals, Inc. (PCSA)Pres. Research & DevelopmentOpen Market Purchase1,786$2.57$4,590
May 15, 2026Processa Pharmaceuticals, Inc. (PCSA)Pres. Research & DevelopmentOpen Market Purchase1,545$2.97$4,589
Subscribe to see more data